Given the diverse phenotypes observed in COA7-related disorders, in addition to CMT and SCD, it is recommended to include the COA7 gene in disease-associated gene panels for various conditions, such as hereditary dystonia, familial Parkinson’s disease, leukoencephalopathy, and hereditary spastic paraplegia. This evidence concerns the gene COA7 and Schnyder corneal dystrophy.